Clinical Support
  • American College of Obstetricians and Gynecologists (ACOG) 2011 Annual Clinical Meeting
    • Pharmacokinetic Profile of AG200-15, a Transdermal Contraceptive Delivery System, in Healthy Women Abstract and Poster will be available May 2011
      Abstract Poster
    • Ovarian Activity in Obese and Non-Obese Women Treated with AG200-15, a Transdermal Contraceptive Abstract and Poster will be available May 2011
      Abstract Poster

  • Stanczyk, et al. Paper published in Hormones, Molecular Biology and Clinical Investigation, April 2011
    • Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel
      Publication

  • American Society for Reproductive Medicine (ASRM) 2010 Annual Meeting
    • Evaluation of Exposure to Ethinyl Estradiol (EE) with a Low Dose Combination Transdermal Contraceptive Delivery System (AG200-15) Compared to Low-Dose Combination Oral Contraceptive.
      Abstract Poster

  • Hormone Molecular Biology and Clinical Investigation 2010 First International Symposium
    • Pharmacokinetics and Tolerability of Transdermal Contraceptive Delivery Systems (TCDS) Containing Ethinyl Estradiol (EE) and Levonorgestrel (LNG)
      Abstract Poster

  • American College of Obstetricians and Gynecologists (ACOG) 2009 Annual Clinical Meeting
    • Pharmacokinetics: Contraceptive Patches Containing Levonorgestrel and Ethinyl Estradiol vs. Levlen®
      Abstract Poster
    • Ovulation Suppression and Cycle Control of Ethinyl Estradiol and Levonorgestrel Combination Patches
      Abstract Poster
© The American College of Obstetricians and Gynecologists. Used with permission.